Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging

Journal of Nuclear Cardiology

Volumn 15, Issue 1, 2008, Pages 127-136

  Chen, Ji ^a   Henneman, Maureen M ^b   Trimble, Mark A ^c   Bax, Jeroen J ^b   Borges Neto, Salvador ^c   Iskandrian, Ami E ^d   Nichols, Kenneth J ^e   Garcia, Ernest V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Northwell Health   (United States)

Author keywords

cardiac resynchronization therapy; electrocardiography gated single photon emission computed tomography; Heart failure; left ventricular dyssynchrony; myocardial perfusion imaging

Indexed keywords

ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GATED IMAGING; HEALTH CARE ORGANIZATION; HEART CYCLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HUMAN; MALE; MEDICAL ASSESSMENT; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; GATED BLOOD-POOL IMAGING; HEART FAILURE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38849191195     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.11.004     Document Type: Review

References (55)

1. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
2. American Heart Association. Heart disease and stroke statistics: 2006 update (2006), American Heart Association, Dallas (TX)
3. Leclercq C., and Kass D.A. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39 (2002) 194-201
4. Abraham W.T., and Hayes D.L. Cardiac resynchronization therapy for heart failure. Circulation 108 (2003) 2596-2603
5. Leclercq C., and Hare J.M. Ventricular resynchronization: current state of the art. Circulation 109 (2004) 296-299
6. Auricchio A., Stellbrink C., Block M., Sack S., Vogt J., Bakker P., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 99 (1999) 2993-3001
7. Brecker S.J., Xiao H.B., Sparrow J., and Gibson D.G. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 340 (1992) 1308-1312
8. Leclercq C., Faris O., Tunin R., Johnson J., Kato R., Evans F., et al. Systolic Improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 106 (2002) 1760-1763
9. Achilli A., Sassara M., Ficili S., Pontillo D., Achilli P., Alessi C., et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J Am Coll Cardiol 42 (2003) 2117-2124
10. Bax J.J., Bleeker G.B., Marwick T.H., Molhoek S.G., Boersma E., Steendijk P., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
11. Bax J.J., Marwick T.H., Molhoek S.G., Bleeker G.B., van Erven L., Boersma E., et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92 (2003) 1238-1240
12. Bax J.J., Abraham T., Barold S.S., Breithardt O.A., Fung J.W., Garrigue S., et al. Cardiac resynchronization therapy: part 1-issues before device implantation. J Am Coll Cardiol 46 (2005) 2153-2167
13. Godoy I.E., Mor-Avi V., Weinert L., Vignon P., Korcarz C., Spencer K.T., et al. Use of color kinesis for evaluation of left ventricular filing in patients with dilated cardiomyopathy and mitral regurgitation. J Am Coll Cardiol 31 (1998) 1598-1606
14. Suffoletto M.S., Dohi K., Cannesson M., Saba S., and Gorcsan III J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 113 (2006) 960-968
15. Westenberg J.J., Lamb H.J., van der Geest R.J., Bleeker G.B., Holman E.R., Schalij M.J., et al. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging. J Am Coll Cardiol 47 (2006) 2042-2048
16. Delfino J.G., Bhasin M., Cole R., Eisner R.L., Merlino J., Leon A.R., et al. Comparison of myocardial velocities obtained with magnetic resonance phase velocity mapping and tissue Doppler imaging in normal subjects and patients with left ventricular dyssynchrony. J Magn Reson Imaging 24 (2006) 304-311
17. Somsen G.A., Verberne H.J., Burri H., Ratib O., and Righetti A. Ventricular mechanical dyssynchrony and resynchronization therapy in heart failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl Med Commun 27 (2006) 105-112
18. Vilain D., Daou D., Casset-Senon D., Faraggi M., and Le Guludec D. Optimal 3-dimensional method for right and left ventricular Fourier phase analysis in electrocardiography-gated blood-pool SPECT. J Nucl Cardiol 8 (2001) 371-378
19. Botvinick E.H., O'Connell J.W., Kadkade P.P., Glickman S.L., Dae M.W., Cohen T.J., et al. Potential added value of three-dimensional reconstruction and display of single photon emission computed tomographic gated blood pool images. J Nucl Cardiol 5 (1998) 245-255
20. Chen J., Garcia E.V., Folks R.D., Cooke C.D., Faber T.L., Tauxe E.L., et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 12 (2005) 687-695
21. Gheorghiade M., and Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97 (1998) 282-289
22. Cohn J.N., Archibald D.G., Ziesche S., Franciosa J.A., Harston W.E., Tristani F.E., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 314 (1986) 1547-1552
23. Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 (1991) 303-310
24. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 316 (1987) 1429-1435
25. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R.C., and Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320 (1989) 677-683
26. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336 (1997) 525-533
27. Feldman A.M., Bristow M.R., Parmley W.W., Carson P.E., Pepine C.J., Gilbert E.M., et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med 329 (1993) 149-155
28. Packer M., Carver J.R., Rodeheffer R.J., Ivanhoe R.J., DiBianco R., Zeldis S.M., et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325 (1991) 1468-1475
29. Packer M., Gheorghiade M., Young J.B., Costantini P.J., Adams K.F., Cody R.J., et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329 (1993) 1-7
30. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
31. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335 (1996) 1107-1114
32. Singh S.N., Fletcher R.D., Fisher S.G., Singh B.N., Lewis H.D., Deedwania P.C., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 333 (1995) 77-82
33. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325 (1991) 293-302
34. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 327 (1992) 685-691
35. Bart B.A., Shaw L.K., McCants Jr. C.B., Fortin D.F., Lee K.L., Califf R.M., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
36. Bleeker G.B., Kaandorp T.A., Lamb H.J., Boersma E., Steendijk P., de Roos A., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113 (2006) 969-976
37. Champeney D.C. Fourier transform and their physical applications (1973), Academic Press, New York 8-21
38. Hoffman E.J., Huang S.C., and Phelps M.E. Quantitation in positron emission computed tomography: 1. Effect of object size. Comput Assist Tomogr 3 (1979) 299-308
39. Galt J.R., Garcia E.V., and Robbins W.L. Effects of myocardial wall thickness on SPECT quantification. IEEE Trans Med Imaging 9 (1990) 144-150
40. Cooke C.D., Garcia E.V., Cullom S.J., Faber T.L., and Pettigrew R.I. Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data. J Nucl Med 35 (1994) 1185-1192
41. Garcia E., DePuey E.G., Sonnemaker R.E., Neely H.R., DePasquale E.E., Robbins W.L., et al. Quantification of the reversibility of stress induced SPECT thallium-201 myocardial perfusion defects: a multicenter trial using bull's-eye polar maps and standard normal limits. J Nucl Med 31 (1990) 1761-1765
42. Faber T.L., Cooke C.D., Folks R.D., Vansant J.P., Nichols K.J., DePuey E.G., et al. Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. J Nucl Med 40 (1999) 650-659
43. Yu C.M., Chau E., Sanderson J.E., Fan K., Tang M.O., Fung W.H., et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105 (2002) 438-445
44. Sogaard P., Egeblad H., Kim W.Y., Jensen H.K., Pedersen A.K., Kristensen B.Ø., et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 40 (2002) 723-730
45. Henneman M.M., Chen J., Ypenburg C., Dibbets P., Bleeker G.B., Boersma E., et al. Phase analysis of gated myocardial perfusion SPECT compared to tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 49 (2007) 1708-1714
46. Yu C.M., Zhang Q., Fung J.W., Chan H.C., Chan Y.S., Yip G.W., et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 45 (2005) 677-684
47. Yu C.M., Fung W.H., Lin H., Zhang Q., Sanderson J.E., and Lau C.P. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 91 (2003) 684-688
48. Ajmone Marsan N., Henneman M.M., Chen J., Ypenburg C., Dibbets P., Ghio S., et al. Left ventricular dyssynchrony assessed by two 3-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging. Eur J Nucl Med Mol Imaging 35 (2008) 166-173
49. Muramatsu T., Matsumoto K., and Nishimura S. Efficacy of the phase images in Fourier analysis using gated cardiac pool-SPECT for determining the indication for cardiac resynchronization therapy. Circ J 69 (2005) 1521-1526
50. Nichols K., Saouaf R., Ababneh A.A., Barst R.J., Rosenbaum M.S., Groch M.W., et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 9 (2002) 153-160
51. Nichols K.J., Van Tosh A., Siddiqi S., Chen J., and Garcia E.V. Comparison between myocardial perfusion and blood pool gated SPECT measurements of LV dyssynchrony. [abstract]. J Nucl Cardiol 14 (2007) S102-S103
52. Trimble M.A., Borges-Neto S., Smallheiser S., Chen J., Honeycutt E.F., Shaw L.K., et al. Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol 14 (2007) 298-307
53. Henneman M.M., Chen J., Dibbets-Schneider P., Stokkel M.P., Bleeker G.B., Ypenburg C., et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT?. J Nucl Med 48 (2007) 1104-1111
54. Trimble M.A., Velazquez E.J., Adams G.L., et al. Repeatability and reproducibility of phase analysis of gated SPECT myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun (2008) In press
55. Chen J., Faber T.L., Cooke C.D., and Garcia E.V. Technical aspects in multi-harmonic phase analysis of LV dyssynchrony from gated myocardial perfusion SPECT. [abstract]. J Nucl Cardiol 14 (2007) S98